During the past decade, General Hospital Dr. Josip Bencevic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital Dr. Josip Bencevic" #1 sponsor was "CEL-SCI Corporation" with 1 trials, followed by "Daiichi Sankyo, Inc." with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Resverlogix Corp" with 1 trials sponsored and "UMC Utrecht" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Dr. Josip Bencevic" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "Orient Europharma Co., Ltd." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Dr. Josip Bencevic" are "Ventilator Associated Pneumonia" (2 trials), "Atrial Fibrillation" (1 trials), "Complicated Intra-abdominal Infection" (1 trials), "Coronary Artery Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "General Hospital Dr. Josip Bencevic" in a lesser frequency.

Most popular intervention types in "General Hospital Dr. Josip Bencevic" are "Drug" (4 trials), "Biological" (1 trials), "Dietary Supplement" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATM-AVI" (1 trials), "Apabetalone" (1 trials), "Atorvastatin" (1 trials), "COL" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Dr. Josip Bencevic" are 5 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital Dr. Josip Bencevic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in General Hospital Dr. Josip Bencevic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Dr. Josip Bencevic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".